La investigación clínica en vacunasEl futuro

  1. José María Eiros 1
  2. A Pérez Rubio 2
  3. María Rosario Bachiller 1
  1. 1 Universidad de Valladolid
    info

    Universidad de Valladolid

    Valladolid, España

    ROR https://ror.org/01fvbaw18

  2. 2 Hospital Universitario de Valladolid
    info

    Hospital Universitario de Valladolid

    Valladolid, España

    ROR https://ror.org/04fffmj41

Revista:
Revista Electrónica de Biomedicina

ISSN: 1697-090X

Año de publicación: 2018

Número: 1

Páginas: 17-23

Tipo: Artículo

Otras publicaciones en: Revista Electrónica de Biomedicina

Resumen

The field of infectious diseases includes vaccines against bacteria, viruses, fungi and parasites, which employ various strategies and production techniques. They are aimed at the identification of new protective antigens (reverse vaccinology, structural vaccinology and immunommunology), the acquisition or enhancement of immunogenicity (vaccination, system vaccinology) and the use of new adjuvants and delivery modalities, heterologous vaccination, conjugation from polysaccharides to proteins and the adversomic. Among the innovative administration routes: the digestive, mucous, and transcutaneous. And as new types of vaccines: recombinants (with or without vectors), nucleic acids, peptide, attenuated and molecularly inactivated, rearranged viruses (rearranged) and adapted to cold. The criteria that should prevail in order to implement "useful" vaccination strategies in our environment must assess the economic and social impact of prevention programs.